ObsEva SA announced that Ernest Loumaye, MD, PhD, co-founder and member of the board of directors has been appointed as interim chairman following the resignation of Annette Clancy. It is expected that Dr. Loumaye will serve in this position until the 2023 Annual General Meeting of Shareholders, at which time he will be nominated for this position for the upcoming year.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | +9,900.00% | -99.71% |
2023 | ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq | MT |
2023 | ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-99.71% | 11.72K | |
+20.37% | 125B | |
+21.62% | 114B | |
+25.30% | 26.73B | |
-23.23% | 19.43B | |
-18.10% | 16.22B | |
-18.62% | 15.33B | |
+11.19% | 14.42B | |
-48.41% | 14.33B | |
+54.95% | 14.2B |
- Stock Market
- Equities
- OBSEF Stock
- News ObsEva SA
- ObsEva SA Announces Executive Changes